학술논문
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis
Document Type
Article
Author
Source
In Clinical Gastroenterology and Hepatology September 2023 21(10):2597-2605
Subject
Language
ISSN
1542-3565